Home » Topics » BioWorld Science

BioWorld Science
RSS

Origo Biopharma discloses new TGFBR1 inhibitors

April 26, 2022

Jiangsu Chia Tai Tianqing Pharmaceutical researchers synthesize new AKT inhibitors

April 26, 2022

Shenzhen Salubris Pharmaceuticals presents GLP-1 receptor agonists

April 26, 2022

Duality Biologics divulges new ADCs for cancer

April 26, 2022

BeiGene patents new MAP4K1 inhibitors

April 26, 2022

Discovery of novel oridonin analogues as potent anticancer agents

April 26, 2022

ZLD-2218, a novel BRD4 inhibitor for the treatment of kidney fibrosis

April 26, 2022

TNIK as novel therapeutic target in lung squamous cell carcinoma

April 26, 2022

CDK4/6 inhibitor PRT-3645 prolongs survival in glioblastoma and brain-metastatic breast cancers

April 26, 2022

AMG-794, a CLDN6-targeting BiTE for treating lung and ovarian tumors

April 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...